Delivery Order SPE2DB20D2104-SPE2DB25FMPWL
Award Date
5/1/25
Potential Completion Date
5/2/25
Potential Value
$6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,985,711 tablets of 8 mg Ondansetron HCl, a medication used to treat nausea and vomiting. The contract has a firm fixed price of $14,206.08 and a completion date of April 22, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,563,866,919 units of Ondansetron HCL 8 mg tablets, a medication commonly used to treat nausea and vomiting. The firm-fixed-price contract has a ceiling value of $5,111.82 and a period of performance through March 6, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) with...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ondansetron hydrochloride 8 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $6,423.40 and a period of performance through June 4, 2024. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,562,473,545 units of Ondansetron HCL 8 mg tablets, a medication commonly used to treat nausea and vomiting. The contract has a total ceiling value of $14,200.58 and is a firm fixed-price contract with an ultimate completion date of October 16, 2023. The contract is not designated...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,559,478,068 units of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The firm-fixed-price contract has a ceiling value of $7,065.42 and a completion date of January 3, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,958,111 units of Ondansetron HCL 8 mg tablets, a medication used to prevent nausea and vomiting. The contract has a Firm Fixed Price pricing type and a total ceiling value of $17,185.18. It is not set aside for any specific type of business. The contract has an ultimate...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,828,704 units of Ondansetron HCL 8 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $19,733.40 and a completion date of April 8, 2025. It is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,090,414 units of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $47,037.51 and a completion date of January 30, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,756,330 units of Ondansetron ODT 8 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $8,048.13 and a completion date of February 26, 2024. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the delivery of 4,565,069,737 units of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $14,358.35 and a period of performance through July 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...